ICU Medical to Acquire Hospira Infusion Systems From Pfizer for $1B

Medical Devices Directory Forums News & Gossips ICU Medical to Acquire Hospira Infusion Systems From Pfizer for $1B

This topic contains 0 replies, has 1 voice, and was last updated by Profile photo of Brückenkopf GmbH Brückenkopf GmbH 7 months, 2 weeks ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #345

    ICU Medical and Pfizer announced that they have entered into a definitive agreement under which ICU Medical will acquire all of Pfizer’s global infusion therapy business, Hospira Infusion Systems (HIS), for $1 billion in cash and stock. The Hospira Infusion Systems business includes IV pumps, solutions, and devices that, when combined with ICU Medical’s existing businesses, will create a leading pure-play infusion therapy company, with estimated pro forma combined revenues of approximately $1.45 billion based on trailing twelve month results as of June 2016.

    Under the terms of the agreement, Pfizer will receive approximately $400 million in newly issued shares of ICU Medical common stock and $600 million in cash from ICU Medical subject to customary adjustment for net working capital. Upon completion of the transaction, which the companies expect to occur in the first quarter of 2017 subject to customary closing conditions including required regulatory approvals, Pfizer will own approximately 16.6 percent of ICU Medical.  In addition, so long as Pfizer continues to hold 10% or more of ICU Medical’s common equity, it will have the right to nominate one director to the company’s board of directors in ICU Medical’s proxy materials, and Pfizer has agreed to certain restrictions on transfer of its shares for at least 18 months.

    Source: Pfizer

    Share
Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.

Share